Literature DB >> 14904886

Some actions of hexamethonium and certain homologues.

R WIEN, D F J MASON.   

Abstract

Entities:  

Keywords:  AUTONOMIC DRUGS/effects; GANGLIA, AUTONOMIC/effect of drugs on; MUSCLE RELAXANTS

Mesh：

Substances：

Year:  1951        PMID： 14904886      PMCID： PMC1509152          DOI： 10.1111/j.1476-5381.1951.tb00672.x

Source DB:  PubMed          Journal:  Br J Pharmacol Chemother        ISSN： 0366-0826


× No keyword cloud information.
  11 in total

1.  Hexamethonium bitartrate and other hexaalkonium salts.

Authors:  H J BARBER; K GAIMSTER
Journal:  J Pharm Pharmacol       Date:  1951-10       Impact factor: 3.765

2.  A method for estimating peptic activity in gastric contents.

Authors:  J N Hunt
Journal:  Biochem J       Date:  1948       Impact factor: 3.857

3.  The interrelation of prostigmine, adrenaline and ephedrine in skeletal muscle.

Authors:  E Bülbring; J H Burn
Journal:  J Physiol       Date:  1942-08-18       Impact factor: 5.182

4.  Unmasking, after cholinergic paralysis by botulinum toxin, of a reversed action of nicotine on the mammalian intestine, revealing the probable presence of local inhibitory ganglion cells in the enteric plexuses.

Authors:  N AMBACHE
Journal:  Br J Pharmacol Chemother       Date:  1951-03

5.  Excretion of the methonium compounds.

Authors:  G E MILNE; S OLEESKY
Journal:  Lancet       Date:  1951-04-21       Impact factor: 79.321

6.  Paralysis of autonomic ganglia by methonium salts.

Authors:  W D M PATON; E J ZAIMIS
Journal:  Br J Pharmacol Chemother       Date:  1951-03

7.  Pharmacology of the coronary circulation.

Authors:  R WEGRIA
Journal:  Pharmacol Rev       Date:  1951-06       Impact factor: 25.468

8.  The synthesis of methonium compounds, their isolation from urine, and their photometric determination.

Authors:  E J ZAIMIS
Journal:  Br J Pharmacol Chemother       Date:  1950-09

9.  Ganglionic blocking agents.

Authors:  G K MOE; W A FREYBURGER
Journal:  J Pharmacol Exp Ther       Date:  1950-04       Impact factor: 4.030

10.  Effect of hexamethonium iodide on gastric secretion and motility.

Authors:  A W KAY; A N SMITH
Journal:  Br Med J       Date:  1950-02-25
View more
  14 in total

1.  The actions of heterocyclic bisquaternary compounds, especially of a pyrrolidinium series.

Authors:  D F MASON; R WIEN
Journal:  Br J Pharmacol Chemother       Date:  1955-03

2.  Assessment of depressor activity and mydriatic activity of hexamethonium analogues.

Authors:  J G BLACKMAN; F N FASTIER; C M PATEL; L C WONG
Journal:  Br J Pharmacol Chemother       Date:  1956-09

3.  The ganglion-blocking properties of hexamethylene bisdialkylsulphonium salts.

Authors:  R B BARLOW; J R VANE
Journal:  Br J Pharmacol Chemother       Date:  1956-06

4.  [Enzyme and acid secretion in basal secretion and gastric secretions stimulated by insulin and histamine under the effect of parasympatholytic substances and ganglion blocking agents].

Authors:  R MERTEN; W FETSCHER
Journal:  Klin Wochenschr       Date:  1956-01-01

5.  Anticholinesterases in the heart-lung preparation.

Authors:  J H BURN; J M WALKER
Journal:  J Physiol       Date:  1954-06-28       Impact factor: 5.182

6.  The pharmacological actions of a series of phenyl alkane p-alpha-bis (trialkylammonium) compounds.

Authors:  R WIEN; D F MASON
Journal:  Br J Pharmacol Chemother       Date:  1953-09

7.  Ganglionic blocking substance and their significance in the relief of pain.

Authors:  E J ZAIMIS
Journal:  Acta Neuroveg (Wien)       Date:  1953

8.  Mydriasis in the mouse: a quantitative method of estimating parasympathetic ganglion block.

Authors:  N D EDGE
Journal:  Br J Pharmacol Chemother       Date:  1953-03

9.  Effects of hexamethonium on normal individuals in relation to its concentration in the plasma.

Authors:  B MORRISON; W D M PATON
Journal:  Br Med J       Date:  1953-06-13

10.  The ganglion blocking properties of homologous compounds in the methonium series.

Authors:  R WIEN; D F J MASON; N D EDGE; G T LANGSTON
Journal:  Br J Pharmacol Chemother       Date:  1952-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.